ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
3
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
3
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Sterile Intravenous (IV) Solution Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-2T1330
Home | Market Reports | Health| Nursing
Global Sterile Intravenous IV Solution Market Insights Forecast to 2028
BUY CHAPTERS

Global Sterile Intravenous (IV) Solution Market Insights, Forecast to 2030

Code: QYRE-Auto-2T1330
Report
December 2024
Pages:112
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
B. Braun Medical Inc.
Technoflex
Baxter International
ICU Medical Inc
Mckesson
Amsino
Wallcur
Hebei Guangren Pharmaceutical Technology
Xi'an Libang Alliance Enterprise Management
Livzon Group
Jiangsu Hengfengqiang Biotechnology
Hospira

Sterile Intravenous (IV) Solution Market

Sterile Intravenous (IV), also known as sterile Intravenous therapy is a therapy that delivers liquid which is in medical use into a vein.
Market Analysis and Insights: Global Sterile Intravenous (IV) Solution Market
The global Sterile Intravenous (IV) Solution market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Sterile Intravenous (IV) Solution is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Sterile Intravenous (IV) Solution is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Sterile Intravenous (IV) Solution is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key companies of Sterile Intravenous (IV) Solution include B. Braun Medical Inc., Technoflex, Baxter International, ICU Medical, Inc, Mckesson, Amsino, Wallcur, Hebei Guangren Pharmaceutical Technology and Jiangsu Hengfengqiang Biotechnology, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Sterile Intravenous (IV) Solution is widely used in various fields, such as Medications, NutritionNutrition, Blood-based Products and Others, etc. Medications provides greatest supports to the Sterile Intravenous (IV) Solution industry development. In 2023, global % revenue of Sterile Intravenous (IV) Solution went into Medications filed and the proportion will reach to % in 2030.
Report Covers:
This report presents an overview of global market for Sterile Intravenous (IV) Solution market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Sterile Intravenous (IV) Solution, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Sterile Intravenous (IV) Solution, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Sterile Intravenous (IV) Solution revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Sterile Intravenous (IV) Solution market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Sterile Intravenous (IV) Solution revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Sterile Intravenous (IV) Solution Market Report

Report Metric Details
Report Name Sterile Intravenous (IV) Solution Market
Segment by Type
Segment by Application
  • Medications
  • NutritionNutrition
  • Blood-based Products
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company B. Braun Medical Inc., Technoflex, Baxter International, ICU Medical, Inc, Mckesson, Amsino, Wallcur, Hebei Guangren Pharmaceutical Technology, Jiangsu Hengfengqiang Biotechnology, Hospira, Xi'an Libang Alliance Enterprise Management, Livzon Group
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of Sterile Intravenous (IV) Solution in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Sterile Intravenous (IV) Solution companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 8: China by Type, and by Application, revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Sterile Intravenous (IV) Solution revenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the Sterile Intravenous (IV) Solution Market report?

Ans: The main players in the Sterile Intravenous (IV) Solution Market are B. Braun Medical Inc., Technoflex, Baxter International, ICU Medical, Inc, Mckesson, Amsino, Wallcur, Hebei Guangren Pharmaceutical Technology, Jiangsu Hengfengqiang Biotechnology, Hospira, Xi'an Libang Alliance Enterprise Management, Livzon Group

What are the Application segmentation covered in the Sterile Intravenous (IV) Solution Market report?

Ans: The Applications covered in the Sterile Intravenous (IV) Solution Market report are Medications, NutritionNutrition, Blood-based Products, Others

What are the Type segmentation covered in the Sterile Intravenous (IV) Solution Market report?

Ans: The Types covered in the Sterile Intravenous (IV) Solution Market report are Crystalloids, Colloids, Others

Recommended Reports

Intravenous Devices

Sterile Medical Consumables

Intravenous Solutions and Adjacent

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sterile Intravenous (IV) Solution Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Crystalloids
1.2.3 Colloids
1.2.4 Others
1.3 Market by Application
1.3.1 Global Sterile Intravenous (IV) Solution Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Medications
1.3.3 NutritionNutrition
1.3.4 Blood-based Products
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Sterile Intravenous (IV) Solution Market Perspective (2019-2030)
2.2 Global Sterile Intravenous (IV) Solution Growth Trends by Region
2.2.1 Sterile Intravenous (IV) Solution Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Sterile Intravenous (IV) Solution Historic Market Size by Region (2019-2024)
2.2.3 Sterile Intravenous (IV) Solution Forecasted Market Size by Region (2025-2030)
2.3 Sterile Intravenous (IV) Solution Market Dynamics
2.3.1 Sterile Intravenous (IV) Solution Industry Trends
2.3.2 Sterile Intravenous (IV) Solution Market Drivers
2.3.3 Sterile Intravenous (IV) Solution Market Challenges
2.3.4 Sterile Intravenous (IV) Solution Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Sterile Intravenous (IV) Solution by Players
3.1.1 Global Sterile Intravenous (IV) Solution Revenue by Players (2019-2024)
3.1.2 Global Sterile Intravenous (IV) Solution Revenue Market Share by Players (2019-2024)
3.2 Global Sterile Intravenous (IV) Solution Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Sterile Intravenous (IV) Solution, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Sterile Intravenous (IV) Solution Market Concentration Ratio
3.4.1 Global Sterile Intravenous (IV) Solution Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sterile Intravenous (IV) Solution Revenue in 2023
3.5 Global Key Players of Sterile Intravenous (IV) Solution Head office and Area Served
3.6 Global Key Players of Sterile Intravenous (IV) Solution, Product and Application
3.7 Global Key Players of Sterile Intravenous (IV) Solution, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Sterile Intravenous (IV) Solution Breakdown Data by Type
4.1 Global Sterile Intravenous (IV) Solution Historic Market Size by Type (2019-2024)
4.2 Global Sterile Intravenous (IV) Solution Forecasted Market Size by Type (2025-2030)
5 Sterile Intravenous (IV) Solution Breakdown Data by Application
5.1 Global Sterile Intravenous (IV) Solution Historic Market Size by Application (2019-2024)
5.2 Global Sterile Intravenous (IV) Solution Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Sterile Intravenous (IV) Solution Market Size (2019-2030)
6.2 North America Sterile Intravenous (IV) Solution Market Size by Type
6.2.1 North America Sterile Intravenous (IV) Solution Market Size by Type (2019-2024)
6.2.2 North America Sterile Intravenous (IV) Solution Market Size by Type (2025-2030)
6.2.3 North America Sterile Intravenous (IV) Solution Market Share by Type (2019-2030)
6.3 North America Sterile Intravenous (IV) Solution Market Size by Application
6.3.1 North America Sterile Intravenous (IV) Solution Market Size by Application (2019-2024)
6.3.2 North America Sterile Intravenous (IV) Solution Market Size by Application (2025-2030)
6.3.3 North America Sterile Intravenous (IV) Solution Market Share by Application (2019-2030)
6.4 North America Sterile Intravenous (IV) Solution Market Size by Country
6.4.1 North America Sterile Intravenous (IV) Solution Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Sterile Intravenous (IV) Solution Market Size by Country (2019-2024)
6.4.3 North America Sterile Intravenous (IV) Solution Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Sterile Intravenous (IV) Solution Market Size (2019-2030)
7.2 Europe Sterile Intravenous (IV) Solution Market Size by Type
7.2.1 Europe Sterile Intravenous (IV) Solution Market Size by Type (2019-2024)
7.2.2 Europe Sterile Intravenous (IV) Solution Market Size by Type (2025-2030)
7.2.3 Europe Sterile Intravenous (IV) Solution Market Share by Type (2019-2030)
7.3 Europe Sterile Intravenous (IV) Solution Market Size by Application
7.3.1 Europe Sterile Intravenous (IV) Solution Market Size by Application (2019-2024)
7.3.2 Europe Sterile Intravenous (IV) Solution Market Size by Application (2025-2030)
7.3.3 Europe Sterile Intravenous (IV) Solution Market Share by Application (2019-2030)
7.4 Europe Sterile Intravenous (IV) Solution Market Size by Country
7.4.1 Europe Sterile Intravenous (IV) Solution Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Sterile Intravenous (IV) Solution Market Size by Country (2019-2024)
7.4.3 Europe Sterile Intravenous (IV) Solution Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Sterile Intravenous (IV) Solution Market Size (2019-2030)
8.2 China Sterile Intravenous (IV) Solution Market Size by Type
8.2.1 China Sterile Intravenous (IV) Solution Market Size by Type (2019-2024)
8.2.2 China Sterile Intravenous (IV) Solution Market Size by Type (2025-2030)
8.2.3 China Sterile Intravenous (IV) Solution Market Share by Type (2019-2030)
8.3 China Sterile Intravenous (IV) Solution Market Size by Application
8.3.1 China Sterile Intravenous (IV) Solution Market Size by Application (2019-2024)
8.3.2 China Sterile Intravenous (IV) Solution Market Size by Application (2025-2030)
8.3.3 China Sterile Intravenous (IV) Solution Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Sterile Intravenous (IV) Solution Market Size (2019-2030)
9.2 Asia Sterile Intravenous (IV) Solution Market Size by Type
9.2.1 Asia Sterile Intravenous (IV) Solution Market Size by Type (2019-2024)
9.2.2 Asia Sterile Intravenous (IV) Solution Market Size by Type (2025-2030)
9.2.3 Asia Sterile Intravenous (IV) Solution Market Share by Type (2019-2030)
9.3 Asia Sterile Intravenous (IV) Solution Market Size by Application
9.3.1 Asia Sterile Intravenous (IV) Solution Market Size by Application (2019-2024)
9.3.2 Asia Sterile Intravenous (IV) Solution Market Size by Application (2025-2030)
9.3.3 Asia Sterile Intravenous (IV) Solution Market Share by Application (2019-2030)
9.4 Asia Sterile Intravenous (IV) Solution Market Size by Region
9.4.1 Asia Sterile Intravenous (IV) Solution Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Sterile Intravenous (IV) Solution Market Size by Region (2019-2024)
9.4.3 Asia Sterile Intravenous (IV) Solution Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Sterile Intravenous (IV) Solution Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Sterile Intravenous (IV) Solution Market Size by Type
10.2.1 Middle East, Africa, and Latin America Sterile Intravenous (IV) Solution Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Sterile Intravenous (IV) Solution Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Sterile Intravenous (IV) Solution Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Sterile Intravenous (IV) Solution Market Size by Application
10.3.1 Middle East, Africa, and Latin America Sterile Intravenous (IV) Solution Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Sterile Intravenous (IV) Solution Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Sterile Intravenous (IV) Solution Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Sterile Intravenous (IV) Solution Market Size by Country
10.4.1 Middle East, Africa, and Latin America Sterile Intravenous (IV) Solution Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Sterile Intravenous (IV) Solution Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Sterile Intravenous (IV) Solution Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 B. Braun Medical Inc.
11.1.1 B. Braun Medical Inc. Company Details
11.1.2 B. Braun Medical Inc. Business Overview
11.1.3 B. Braun Medical Inc. Sterile Intravenous (IV) Solution Introduction
11.1.4 B. Braun Medical Inc. Revenue in Sterile Intravenous (IV) Solution Business (2019-2024)
11.1.5 B. Braun Medical Inc. Recent Developments
11.2 Technoflex
11.2.1 Technoflex Company Details
11.2.2 Technoflex Business Overview
11.2.3 Technoflex Sterile Intravenous (IV) Solution Introduction
11.2.4 Technoflex Revenue in Sterile Intravenous (IV) Solution Business (2019-2024)
11.2.5 Technoflex Recent Developments
11.3 Baxter International
11.3.1 Baxter International Company Details
11.3.2 Baxter International Business Overview
11.3.3 Baxter International Sterile Intravenous (IV) Solution Introduction
11.3.4 Baxter International Revenue in Sterile Intravenous (IV) Solution Business (2019-2024)
11.3.5 Baxter International Recent Developments
11.4 ICU Medical, Inc
11.4.1 ICU Medical, Inc Company Details
11.4.2 ICU Medical, Inc Business Overview
11.4.3 ICU Medical, Inc Sterile Intravenous (IV) Solution Introduction
11.4.4 ICU Medical, Inc Revenue in Sterile Intravenous (IV) Solution Business (2019-2024)
11.4.5 ICU Medical, Inc Recent Developments
11.5 Mckesson
11.5.1 Mckesson Company Details
11.5.2 Mckesson Business Overview
11.5.3 Mckesson Sterile Intravenous (IV) Solution Introduction
11.5.4 Mckesson Revenue in Sterile Intravenous (IV) Solution Business (2019-2024)
11.5.5 Mckesson Recent Developments
11.6 Amsino
11.6.1 Amsino Company Details
11.6.2 Amsino Business Overview
11.6.3 Amsino Sterile Intravenous (IV) Solution Introduction
11.6.4 Amsino Revenue in Sterile Intravenous (IV) Solution Business (2019-2024)
11.6.5 Amsino Recent Developments
11.7 Wallcur
11.7.1 Wallcur Company Details
11.7.2 Wallcur Business Overview
11.7.3 Wallcur Sterile Intravenous (IV) Solution Introduction
11.7.4 Wallcur Revenue in Sterile Intravenous (IV) Solution Business (2019-2024)
11.7.5 Wallcur Recent Developments
11.8 Hebei Guangren Pharmaceutical Technology
11.8.1 Hebei Guangren Pharmaceutical Technology Company Details
11.8.2 Hebei Guangren Pharmaceutical Technology Business Overview
11.8.3 Hebei Guangren Pharmaceutical Technology Sterile Intravenous (IV) Solution Introduction
11.8.4 Hebei Guangren Pharmaceutical Technology Revenue in Sterile Intravenous (IV) Solution Business (2019-2024)
11.8.5 Hebei Guangren Pharmaceutical Technology Recent Developments
11.9 Jiangsu Hengfengqiang Biotechnology
11.9.1 Jiangsu Hengfengqiang Biotechnology Company Details
11.9.2 Jiangsu Hengfengqiang Biotechnology Business Overview
11.9.3 Jiangsu Hengfengqiang Biotechnology Sterile Intravenous (IV) Solution Introduction
11.9.4 Jiangsu Hengfengqiang Biotechnology Revenue in Sterile Intravenous (IV) Solution Business (2019-2024)
11.9.5 Jiangsu Hengfengqiang Biotechnology Recent Developments
11.10 Hospira
11.10.1 Hospira Company Details
11.10.2 Hospira Business Overview
11.10.3 Hospira Sterile Intravenous (IV) Solution Introduction
11.10.4 Hospira Revenue in Sterile Intravenous (IV) Solution Business (2019-2024)
11.10.5 Hospira Recent Developments
11.11 Jiangsu Hengfengqiang Biotechnology
11.11.1 Jiangsu Hengfengqiang Biotechnology Company Details
11.11.2 Jiangsu Hengfengqiang Biotechnology Business Overview
11.11.3 Jiangsu Hengfengqiang Biotechnology Sterile Intravenous (IV) Solution Introduction
11.11.4 Jiangsu Hengfengqiang Biotechnology Revenue in Sterile Intravenous (IV) Solution Business (2019-2024)
11.11.5 Jiangsu Hengfengqiang Biotechnology Recent Developments
11.12 Hospira
11.12.1 Hospira Company Details
11.12.2 Hospira Business Overview
11.12.3 Hospira Sterile Intravenous (IV) Solution Introduction
11.12.4 Hospira Revenue in Sterile Intravenous (IV) Solution Business (2019-2024)
11.12.5 Hospira Recent Developments
11.13 Xi'an Libang Alliance Enterprise Management
11.13.1 Xi'an Libang Alliance Enterprise Management Company Details
11.13.2 Xi'an Libang Alliance Enterprise Management Business Overview
11.13.3 Xi'an Libang Alliance Enterprise Management Sterile Intravenous (IV) Solution Introduction
11.13.4 Xi'an Libang Alliance Enterprise Management Revenue in Sterile Intravenous (IV) Solution Business (2019-2024)
11.13.5 Xi'an Libang Alliance Enterprise Management Recent Developments
11.14 Livzon Group
11.14.1 Livzon Group Company Details
11.14.2 Livzon Group Business Overview
11.14.3 Livzon Group Sterile Intravenous (IV) Solution Introduction
11.14.4 Livzon Group Revenue in Sterile Intravenous (IV) Solution Business (2019-2024)
11.14.5 Livzon Group Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
FEATURED COMPANIES
B. Braun Medical Inc.
Technoflex
Baxter International
ICU Medical Inc
Mckesson
Amsino
Wallcur
Hebei Guangren Pharmaceutical Technology
Xi'an Libang Alliance Enterprise Management
Livzon Group
Jiangsu Hengfengqiang Biotechnology
Hospira
List of Tables
    Table 1. Global Sterile Intravenous (IV) Solution Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Crystalloids
    Table 3. Key Players of Colloids
    Table 4. Key Players of Others
    Table 5. Global Sterile Intravenous (IV) Solution Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 6. Global Sterile Intravenous (IV) Solution Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 7. Global Sterile Intravenous (IV) Solution Market Size by Region (2019-2024) & (US$ Million)
    Table 8. Global Sterile Intravenous (IV) Solution Market Share by Region (2019-2024)
    Table 9. Global Sterile Intravenous (IV) Solution Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 10. Global Sterile Intravenous (IV) Solution Market Share by Region (2025-2030)
    Table 11. Sterile Intravenous (IV) Solution Market Trends
    Table 12. Sterile Intravenous (IV) Solution Market Drivers
    Table 13. Sterile Intravenous (IV) Solution Market Challenges
    Table 14. Sterile Intravenous (IV) Solution Market Restraints
    Table 15. Global Sterile Intravenous (IV) Solution Revenue by Players (2019-2024) & (US$ Million)
    Table 16. Global Sterile Intravenous (IV) Solution Revenue Share by Players (2019-2024)
    Table 17. Global Top Sterile Intravenous (IV) Solution by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sterile Intravenous (IV) Solution as of 2023)
    Table 18. Global Sterile Intravenous (IV) Solution Industry Ranking 2022 VS 2023 VS 2024
    Table 19. Global 5 Largest Players Market Share by Sterile Intravenous (IV) Solution Revenue (CR5 and HHI) & (2019-2024)
    Table 20. Global Key Players of Sterile Intravenous (IV) Solution, Headquarters and Area Served
    Table 21. Global Key Players of Sterile Intravenous (IV) Solution, Product and Application
    Table 22. Global Key Players of Sterile Intravenous (IV) Solution, Product and Application
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Sterile Intravenous (IV) Solution Market Size by Type (2019-2024) & (US$ Million)
    Table 25. Global Sterile Intravenous (IV) Solution Revenue Market Share by Type (2019-2024)
    Table 26. Global Sterile Intravenous (IV) Solution Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 27. Global Sterile Intravenous (IV) Solution Revenue Market Share by Type (2025-2030)
    Table 28. Global Sterile Intravenous (IV) Solution Market Size by Application (2019-2024) & (US$ Million)
    Table 29. Global Sterile Intravenous (IV) Solution Revenue Share by Application (2019-2024)
    Table 30. Global Sterile Intravenous (IV) Solution Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 31. Global Sterile Intravenous (IV) Solution Revenue Share by Application (2025-2030)
    Table 32. North America Sterile Intravenous (IV) Solution Market Size by Type (2019-2024) & (US$ Million)
    Table 33. North America Sterile Intravenous (IV) Solution Market Size by Type (2025-2030) & (US$ Million)
    Table 34. North America Sterile Intravenous (IV) Solution Market Size by Application (2019-2024) & (US$ Million)
    Table 35. North America Sterile Intravenous (IV) Solution Market Size by Application (2025-2030) & (US$ Million)
    Table 36. North America Sterile Intravenous (IV) Solution Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 37. North America Sterile Intravenous (IV) Solution Market Size by Country (2019-2024) & (US$ Million)
    Table 38. North America Sterile Intravenous (IV) Solution Market Size by Country (2025-2030) & (US$ Million)
    Table 39. Europe Sterile Intravenous (IV) Solution Market Size by Type (2019-2024) & (US$ Million)
    Table 40. Europe Sterile Intravenous (IV) Solution Market Size by Type (2025-2030) & (US$ Million)
    Table 41. Europe Sterile Intravenous (IV) Solution Market Size by Application (2019-2024) & (US$ Million)
    Table 42. Europe Sterile Intravenous (IV) Solution Market Size by Application (2025-2030) & (US$ Million)
    Table 43. Europe Sterile Intravenous (IV) Solution Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 44. Europe Sterile Intravenous (IV) Solution Market Size by Country (2019-2024) & (US$ Million)
    Table 45. Europe Sterile Intravenous (IV) Solution Market Size by Country (2025-2030) & (US$ Million)
    Table 46. China Sterile Intravenous (IV) Solution Market Size by Type (2019-2024) & (US$ Million)
    Table 47. China Sterile Intravenous (IV) Solution Market Size by Type (2025-2030) & (US$ Million)
    Table 48. China Sterile Intravenous (IV) Solution Market Size by Application (2019-2024) & (US$ Million)
    Table 49. China Sterile Intravenous (IV) Solution Market Size by Application (2025-2030) & (US$ Million)
    Table 50. Asia Sterile Intravenous (IV) Solution Market Size by Type (2019-2024) & (US$ Million)
    Table 51. Asia Sterile Intravenous (IV) Solution Market Size by Type (2025-2030) & (US$ Million)
    Table 52. Asia Sterile Intravenous (IV) Solution Market Size by Application (2019-2024) & (US$ Million)
    Table 53. Asia Sterile Intravenous (IV) Solution Market Size by Application (2025-2030) & (US$ Million)
    Table 54. Asia Sterile Intravenous (IV) Solution Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 55. Asia Sterile Intravenous (IV) Solution Market Size by Region (2019-2024) & (US$ Million)
    Table 56. Asia Sterile Intravenous (IV) Solution Market Size by Region (2025-2030) & (US$ Million)
    Table 57. Middle East, Africa, and Latin America Sterile Intravenous (IV) Solution Market Size by Type (2019-2024) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Sterile Intravenous (IV) Solution Market Size by Type (2025-2030) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Sterile Intravenous (IV) Solution Market Size by Application (2019-2024) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Sterile Intravenous (IV) Solution Market Size by Application (2025-2030) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Sterile Intravenous (IV) Solution Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 62. Middle East, Africa, and Latin America Sterile Intravenous (IV) Solution Market Size by Country (2019-2024) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America Sterile Intravenous (IV) Solution Market Size by Country (2025-2030) & (US$ Million)
    Table 64. B. Braun Medical Inc. Company Details
    Table 65. B. Braun Medical Inc. Business Overview
    Table 66. B. Braun Medical Inc. Sterile Intravenous (IV) Solution Product
    Table 67. B. Braun Medical Inc. Revenue in Sterile Intravenous (IV) Solution Business (2019-2024) & (US$ Million)
    Table 68. B. Braun Medical Inc. Recent Developments
    Table 69. Technoflex Company Details
    Table 70. Technoflex Business Overview
    Table 71. Technoflex Sterile Intravenous (IV) Solution Product
    Table 72. Technoflex Revenue in Sterile Intravenous (IV) Solution Business (2019-2024) & (US$ Million)
    Table 73. Technoflex Recent Developments
    Table 74. Baxter International Company Details
    Table 75. Baxter International Business Overview
    Table 76. Baxter International Sterile Intravenous (IV) Solution Product
    Table 77. Baxter International Revenue in Sterile Intravenous (IV) Solution Business (2019-2024) & (US$ Million)
    Table 78. Baxter International Recent Developments
    Table 79. ICU Medical, Inc Company Details
    Table 80. ICU Medical, Inc Business Overview
    Table 81. ICU Medical, Inc Sterile Intravenous (IV) Solution Product
    Table 82. ICU Medical, Inc Revenue in Sterile Intravenous (IV) Solution Business (2019-2024) & (US$ Million)
    Table 83. ICU Medical, Inc Recent Developments
    Table 84. Mckesson Company Details
    Table 85. Mckesson Business Overview
    Table 86. Mckesson Sterile Intravenous (IV) Solution Product
    Table 87. Mckesson Revenue in Sterile Intravenous (IV) Solution Business (2019-2024) & (US$ Million)
    Table 88. Mckesson Recent Developments
    Table 89. Amsino Company Details
    Table 90. Amsino Business Overview
    Table 91. Amsino Sterile Intravenous (IV) Solution Product
    Table 92. Amsino Revenue in Sterile Intravenous (IV) Solution Business (2019-2024) & (US$ Million)
    Table 93. Amsino Recent Developments
    Table 94. Wallcur Company Details
    Table 95. Wallcur Business Overview
    Table 96. Wallcur Sterile Intravenous (IV) Solution Product
    Table 97. Wallcur Revenue in Sterile Intravenous (IV) Solution Business (2019-2024) & (US$ Million)
    Table 98. Wallcur Recent Developments
    Table 99. Hebei Guangren Pharmaceutical Technology Company Details
    Table 100. Hebei Guangren Pharmaceutical Technology Business Overview
    Table 101. Hebei Guangren Pharmaceutical Technology Sterile Intravenous (IV) Solution Product
    Table 102. Hebei Guangren Pharmaceutical Technology Revenue in Sterile Intravenous (IV) Solution Business (2019-2024) & (US$ Million)
    Table 103. Hebei Guangren Pharmaceutical Technology Recent Developments
    Table 104. Jiangsu Hengfengqiang Biotechnology Company Details
    Table 105. Jiangsu Hengfengqiang Biotechnology Business Overview
    Table 106. Jiangsu Hengfengqiang Biotechnology Sterile Intravenous (IV) Solution Product
    Table 107. Jiangsu Hengfengqiang Biotechnology Revenue in Sterile Intravenous (IV) Solution Business (2019-2024) & (US$ Million)
    Table 108. Jiangsu Hengfengqiang Biotechnology Recent Developments
    Table 109. Hospira Company Details
    Table 110. Hospira Business Overview
    Table 111. Hospira Sterile Intravenous (IV) Solution Product
    Table 112. Hospira Revenue in Sterile Intravenous (IV) Solution Business (2019-2024) & (US$ Million)
    Table 113. Hospira Recent Developments
    Table 114. Jiangsu Hengfengqiang Biotechnology Company Details
    Table 115. Jiangsu Hengfengqiang Biotechnology Business Overview
    Table 116. Jiangsu Hengfengqiang Biotechnology Sterile Intravenous (IV) Solution Product
    Table 117. Jiangsu Hengfengqiang Biotechnology Revenue in Sterile Intravenous (IV) Solution Business (2019-2024) & (US$ Million)
    Table 118. Jiangsu Hengfengqiang Biotechnology Recent Developments
    Table 119. Hospira Company Details
    Table 120. Hospira Business Overview
    Table 121. Hospira Sterile Intravenous (IV) Solution Product
    Table 122. Hospira Revenue in Sterile Intravenous (IV) Solution Business (2019-2024) & (US$ Million)
    Table 123. Hospira Recent Developments
    Table 124. Xi'an Libang Alliance Enterprise Management Company Details
    Table 125. Xi'an Libang Alliance Enterprise Management Business Overview
    Table 126. Xi'an Libang Alliance Enterprise Management Sterile Intravenous (IV) Solution Product
    Table 127. Xi'an Libang Alliance Enterprise Management Revenue in Sterile Intravenous (IV) Solution Business (2019-2024) & (US$ Million)
    Table 128. Xi'an Libang Alliance Enterprise Management Recent Developments
    Table 129. Livzon Group Company Details
    Table 130. Livzon Group Business Overview
    Table 131. Livzon Group Sterile Intravenous (IV) Solution Product
    Table 132. Livzon Group Revenue in Sterile Intravenous (IV) Solution Business (2019-2024) & (US$ Million)
    Table 133. Livzon Group Recent Developments
    Table 134. Research Programs/Design for This Report
    Table 135. Key Data Information from Secondary Sources
    Table 136. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Sterile Intravenous (IV) Solution Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Sterile Intravenous (IV) Solution Market Share by Type: 2023 VS 2030
    Figure 3. Crystalloids Features
    Figure 4. Colloids Features
    Figure 5. Others Features
    Figure 6. Global Sterile Intravenous (IV) Solution Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 7. Global Sterile Intravenous (IV) Solution Market Share by Application: 2023 VS 2030
    Figure 8. Medications Case Studies
    Figure 9. NutritionNutrition Case Studies
    Figure 10. Blood-based Products Case Studies
    Figure 11. Others Case Studies
    Figure 12. Sterile Intravenous (IV) Solution Report Years Considered
    Figure 13. Global Sterile Intravenous (IV) Solution Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 14. Global Sterile Intravenous (IV) Solution Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 15. Global Sterile Intravenous (IV) Solution Market Share by Region: 2023 VS 2030
    Figure 16. Global Sterile Intravenous (IV) Solution Market Share by Players in 2023
    Figure 17. Global Top Sterile Intravenous (IV) Solution Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sterile Intravenous (IV) Solution as of 2023)
    Figure 18. The Top 10 and 5 Players Market Share by Sterile Intravenous (IV) Solution Revenue in 2023
    Figure 19. North America Sterile Intravenous (IV) Solution Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 20. North America Sterile Intravenous (IV) Solution Market Share by Type (2019-2030)
    Figure 21. North America Sterile Intravenous (IV) Solution Market Share by Application (2019-2030)
    Figure 22. North America Sterile Intravenous (IV) Solution Market Share by Country (2019-2030)
    Figure 23. United States Sterile Intravenous (IV) Solution Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Canada Sterile Intravenous (IV) Solution Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Europe Sterile Intravenous (IV) Solution Market Size YoY (2019-2030) & (US$ Million)
    Figure 26. Europe Sterile Intravenous (IV) Solution Market Share by Type (2019-2030)
    Figure 27. Europe Sterile Intravenous (IV) Solution Market Share by Application (2019-2030)
    Figure 28. Europe Sterile Intravenous (IV) Solution Market Share by Country (2019-2030)
    Figure 29. Germany Sterile Intravenous (IV) Solution Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. France Sterile Intravenous (IV) Solution Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. U.K. Sterile Intravenous (IV) Solution Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Italy Sterile Intravenous (IV) Solution Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Russia Sterile Intravenous (IV) Solution Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Nordic Countries Sterile Intravenous (IV) Solution Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. China Sterile Intravenous (IV) Solution Market Size YoY (2019-2030) & (US$ Million)
    Figure 36. China Sterile Intravenous (IV) Solution Market Share by Type (2019-2030)
    Figure 37. China Sterile Intravenous (IV) Solution Market Share by Application (2019-2030)
    Figure 38. Asia Sterile Intravenous (IV) Solution Market Size YoY (2019-2030) & (US$ Million)
    Figure 39. Asia Sterile Intravenous (IV) Solution Market Share by Type (2019-2030)
    Figure 40. Asia Sterile Intravenous (IV) Solution Market Share by Application (2019-2030)
    Figure 41. Asia Sterile Intravenous (IV) Solution Market Share by Region (2019-2030)
    Figure 42. Japan Sterile Intravenous (IV) Solution Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. South Korea Sterile Intravenous (IV) Solution Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. China Taiwan Sterile Intravenous (IV) Solution Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Southeast Asia Sterile Intravenous (IV) Solution Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. India Sterile Intravenous (IV) Solution Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Australia Sterile Intravenous (IV) Solution Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. Middle East, Africa, and Latin America Sterile Intravenous (IV) Solution Market Size YoY (2019-2030) & (US$ Million)
    Figure 49. Middle East, Africa, and Latin America Sterile Intravenous (IV) Solution Market Share by Type (2019-2030)
    Figure 50. Middle East, Africa, and Latin America Sterile Intravenous (IV) Solution Market Share by Application (2019-2030)
    Figure 51. Middle East, Africa, and Latin America Sterile Intravenous (IV) Solution Market Share by Country (2019-2030)
    Figure 52. Brazil Sterile Intravenous (IV) Solution Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Mexico Sterile Intravenous (IV) Solution Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Turkey Sterile Intravenous (IV) Solution Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Saudi Arabia Sterile Intravenous (IV) Solution Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Israel Sterile Intravenous (IV) Solution Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. GCC Countries Sterile Intravenous (IV) Solution Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 58. B. Braun Medical Inc. Revenue Growth Rate in Sterile Intravenous (IV) Solution Business (2019-2024)
    Figure 59. Technoflex Revenue Growth Rate in Sterile Intravenous (IV) Solution Business (2019-2024)
    Figure 60. Baxter International Revenue Growth Rate in Sterile Intravenous (IV) Solution Business (2019-2024)
    Figure 61. ICU Medical, Inc Revenue Growth Rate in Sterile Intravenous (IV) Solution Business (2019-2024)
    Figure 62. Mckesson Revenue Growth Rate in Sterile Intravenous (IV) Solution Business (2019-2024)
    Figure 63. Amsino Revenue Growth Rate in Sterile Intravenous (IV) Solution Business (2019-2024)
    Figure 64. Wallcur Revenue Growth Rate in Sterile Intravenous (IV) Solution Business (2019-2024)
    Figure 65. Hebei Guangren Pharmaceutical Technology Revenue Growth Rate in Sterile Intravenous (IV) Solution Business (2019-2024)
    Figure 66. Jiangsu Hengfengqiang Biotechnology Revenue Growth Rate in Sterile Intravenous (IV) Solution Business (2019-2024)
    Figure 67. Hospira Revenue Growth Rate in Sterile Intravenous (IV) Solution Business (2019-2024)
    Figure 68. Jiangsu Hengfengqiang Biotechnology Revenue Growth Rate in Sterile Intravenous (IV) Solution Business (2019-2024)
    Figure 69. Hospira Revenue Growth Rate in Sterile Intravenous (IV) Solution Business (2019-2024)
    Figure 70. Xi'an Libang Alliance Enterprise Management Revenue Growth Rate in Sterile Intravenous (IV) Solution Business (2019-2024)
    Figure 71. Livzon Group Revenue Growth Rate in Sterile Intravenous (IV) Solution Business (2019-2024)
    Figure 72. Bottom-up and Top-down Approaches for This Report
    Figure 73. Data Triangulation
    Figure 74. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

Global Intravenous Solutions Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031
Large Volume Intravenous Solution Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
IV Therapy Consumable Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global IV Electrolyte Solutions Market Research Report 2024
Intravenous Therapy IV Bottles Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Sterile IV Packaging Market Research Report 2024
Intravenous IV Therapy and Vein Access Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Sterile IV Containers Market Research Report 2024
Sterile Injection Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Venous Infusion Set Market Research Report 2024
Global Intravenous Solution Compounder Market Research Report 2024
IV Disposable Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Sterile Injectable Drugs Market Research Report 2024
Global IV Solution Bags Market Research Report 2024
Global IV Cannulas Market Research Report 2024
Global IV Administration Sets Market Research Report 2024
Global Intravenous Nutritional Product Market Research Report 2024
Global Vitamin IV Therapy Product Market Research Report 2024
Global IV Bags Market Research Report 2024
Global Injectable Bags Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions